FIELD: medicine, pharmacy.
SUBSTANCE: invention concerns a pharmaceutical composition eliciting hepatoprotective effect. The base of pharmaceutical composition comprises adducts of orotic acid with amino acids or amines as an active substance. The composition comprises effective amount of active substance and special additives in the following ratio of active substance and special additives, wt.-%: active substance, 0.05-40.0; special additives, 60.0-99.95. As special additives the composition comprises starch, mixture of vitamins, lactose, aerosil, talc, stearates, polyvinylpyrrolidone, solid confectionary fat, Tween-80, polyethylene glycol, glycerol, citric acid, benzoic acid, sodium benzoate, correcting dye-substances. Compositions are made as tablets, capsules, lozenges, suppositories, syrups. Also, invention proposes a medicinal agent comprising above said pharmaceutical composition. Invention provides high pharmaco-therapeutical effect with fitness period 2 years, not less.
EFFECT: improved and valuable pharmaceutical properties of composition.
9 cl, 6 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION SHOWING HEPATOPROTECTIVE EFFECT | 1996 |
|
RU2111747C1 |
AN AQUEOUS SOLUTION SHOWING HEPATOPROTECTIVE EFFECT | 1996 |
|
RU2111746C1 |
ADDUCTS OF OROTIC ACID WITH AMINO ACIDS OR AMINES SHOWING HEPATOPROTECTIVE EFFECT | 1993 |
|
RU2047606C1 |
METHOD FOR PRODUCTION OF SIBERIAN CEDAR SEEDS LIQUEUR AND HEPATOPROTECTIVE PREPARATION PRODUCED BY SUCH METHOD | 2014 |
|
RU2545700C1 |
ANTIOXIDANT AND MEMBRANE STABILISING AGENT | 2012 |
|
RU2540466C2 |
"CORSILIN" AS HEPATOPROTECTIVE PRODUCT | 2002 |
|
RU2205637C1 |
HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
USE OF PEGYLATED RECOMBINANT CHIMERIC MOUSE FIBROBLAST-21 GROWTH FACTOR OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN COMPOSITION OF DRUGS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2785582C2 |
INJECTION DRUG FORM FOR TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2012 |
|
RU2504347C1 |
2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
Authors
Dates
2005-07-27—Published
2003-11-12—Filed